HEADER TRANSCRIPTION 19-JUN-19 6PDZ TITLE CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH TITLE 2 SMRT PEPTIDE AND INVERSE AGONIST T0070907 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: B, A; COMPND 4 SYNONYM: PPAR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: NUCLEAR RECEPTOR COREPRESSOR 2; COMPND 8 CHAIN: C, D; COMPND 9 SYNONYM: N-COR2,CTG REPEAT PROTEIN 26,SMAP270,SILENCING MEDIATOR OF COMPND 10 RETINOIC ACID AND THYROID HORMONE RECEPTOR,SMRT,T3 RECEPTOR- COMPND 11 ASSOCIATING FACTOR,TRAC,THYROID-,RETINOIC-ACID-RECEPTOR-ASSOCIATED COMPND 12 COREPRESSOR; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET46; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: NCOR2, CTG26; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS NUCLEAR RECEPTORS, TZDS, DRUG DESIGN, THERAPEUTIC TARGETS, KEYWDS 2 TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR J.SHANG,D.J.KOJETIN REVDAT 3 09-OCT-24 6PDZ 1 REMARK REVDAT 2 11-OCT-23 6PDZ 1 REMARK REVDAT 1 04-MAR-20 6PDZ 0 JRNL AUTH J.SHANG,S.A.MOSURE,J.ZHENG,R.BRUST,J.BASS,A.NICHOLS, JRNL AUTH 2 L.A.SOLT,P.R.GRIFFIN,D.J.KOJETIN JRNL TITL A MOLECULAR SWITCH REGULATING TRANSCRIPTIONAL REPRESSION AND JRNL TITL 2 ACTIVATION OF PPAR GAMMA. JRNL REF NAT COMMUN V. 11 956 2020 JRNL REFN ESSN 2041-1723 JRNL PMID 32075969 JRNL DOI 10.1038/S41467-020-14750-X REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.82 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 38097 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.250 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.8200 - 5.0576 0.99 2740 152 0.1998 0.2486 REMARK 3 2 5.0576 - 4.0158 1.00 2642 146 0.1608 0.1939 REMARK 3 3 4.0158 - 3.5086 1.00 2611 145 0.1681 0.1912 REMARK 3 4 3.5086 - 3.1880 0.99 2568 142 0.1812 0.2268 REMARK 3 5 3.1880 - 2.9596 1.00 2570 143 0.2032 0.2441 REMARK 3 6 2.9596 - 2.7851 1.00 2585 143 0.1925 0.2479 REMARK 3 7 2.7851 - 2.6457 1.00 2549 141 0.1944 0.2601 REMARK 3 8 2.6457 - 2.5305 1.00 2556 141 0.1966 0.2664 REMARK 3 9 2.5305 - 2.4331 1.00 2580 144 0.2002 0.2760 REMARK 3 10 2.4331 - 2.3492 0.99 2503 138 0.2116 0.2886 REMARK 3 11 2.3492 - 2.2758 1.00 2552 142 0.2072 0.2521 REMARK 3 12 2.2758 - 2.2107 1.00 2543 141 0.2139 0.2858 REMARK 3 13 2.2107 - 2.1525 1.00 2545 140 0.2200 0.2854 REMARK 3 14 2.1525 - 2.1000 0.99 2553 142 0.2296 0.2981 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.390 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6PDZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JUN-19. REMARK 100 THE DEPOSITION ID IS D_1000242377. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-APR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97946 REMARK 200 MONOCHROMATOR : LIQUID NITROGEN-COOLED DOUBLE REMARK 200 CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38114 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 37.823 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.03100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.23600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6ONI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULFATE 0.1M MES, PH 6.5 REMARK 280 30% W/V PEG8000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.87800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.30350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.74200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.30350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.87800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.74200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3830 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C, A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE B 262 REMARK 465 LYS B 263 REMARK 465 PHE B 264 REMARK 465 LYS B 265 REMARK 465 HIS B 266 REMARK 465 ILE B 267 REMARK 465 THR B 268 REMARK 465 PRO B 269 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 465 THR C 2337 REMARK 465 GLY C 2351 REMARK 465 LYS C 2352 REMARK 465 TYR C 2353 REMARK 465 ASP C 2354 REMARK 465 GLN C 2355 REMARK 465 TRP C 2356 REMARK 465 GLU C 2357 REMARK 465 GLU C 2358 REMARK 465 GLN A 203 REMARK 465 LEU A 204 REMARK 465 ASN A 205 REMARK 465 PRO A 206 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 SER A 274 REMARK 465 LYS A 275 REMARK 465 GLU A 276 REMARK 465 VAL A 277 REMARK 465 GLU A 460 REMARK 465 THR A 461 REMARK 465 ASP A 462 REMARK 465 MET A 463 REMARK 465 SER A 464 REMARK 465 THR D 2337 REMARK 465 ASN D 2338 REMARK 465 GLY D 2351 REMARK 465 LYS D 2352 REMARK 465 TYR D 2353 REMARK 465 ASP D 2354 REMARK 465 GLN D 2355 REMARK 465 TRP D 2356 REMARK 465 GLU D 2357 REMARK 465 GLU D 2358 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU B 259 106.97 -58.19 REMARK 500 LYS B 458 40.34 -95.86 REMARK 500 GLU B 460 79.43 -118.76 REMARK 500 LEU B 476 -159.41 -122.34 REMARK 500 ASN A 335 -169.05 -126.50 REMARK 500 LEU A 393 46.09 -88.10 REMARK 500 LYS A 458 44.09 -82.26 REMARK 500 LEU A 476 -165.09 -110.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C2412 DISTANCE = 7.61 ANGSTROMS REMARK 525 HOH C2413 DISTANCE = 8.31 ANGSTROMS REMARK 525 HOH A 849 DISTANCE = 5.91 ANGSTROMS REMARK 525 HOH A 850 DISTANCE = 5.97 ANGSTROMS REMARK 525 HOH A 851 DISTANCE = 6.78 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EEY B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide EEY A 501 and CYS A REMARK 800 285 DBREF 6PDZ B 203 477 UNP P37231 PPARG_HUMAN 231 505 DBREF 6PDZ C 2337 2358 UNP Q9Y618 NCOR2_HUMAN 2318 2339 DBREF 6PDZ A 203 477 UNP P37231 PPARG_HUMAN 231 505 DBREF 6PDZ D 2337 2358 UNP Q9Y618 NCOR2_HUMAN 2318 2339 SEQRES 1 B 275 GLN LEU ASN PRO GLU SER ALA ASP LEU ARG ALA LEU ALA SEQRES 2 B 275 LYS HIS LEU TYR ASP SER TYR ILE LYS SER PHE PRO LEU SEQRES 3 B 275 THR LYS ALA LYS ALA ARG ALA ILE LEU THR GLY LYS THR SEQRES 4 B 275 THR ASP LYS SER PRO PHE VAL ILE TYR ASP MET ASN SER SEQRES 5 B 275 LEU MET MET GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE SEQRES 6 B 275 THR PRO LEU GLN GLU GLN SER LYS GLU VAL ALA ILE ARG SEQRES 7 B 275 ILE PHE GLN GLY CYS GLN PHE ARG SER VAL GLU ALA VAL SEQRES 8 B 275 GLN GLU ILE THR GLU TYR ALA LYS SER ILE PRO GLY PHE SEQRES 9 B 275 VAL ASN LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS SEQRES 10 B 275 TYR GLY VAL HIS GLU ILE ILE TYR THR MET LEU ALA SER SEQRES 11 B 275 LEU MET ASN LYS ASP GLY VAL LEU ILE SER GLU GLY GLN SEQRES 12 B 275 GLY PHE MET THR ARG GLU PHE LEU LYS SER LEU ARG LYS SEQRES 13 B 275 PRO PHE GLY ASP PHE MET GLU PRO LYS PHE GLU PHE ALA SEQRES 14 B 275 VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU SEQRES 15 B 275 ALA ILE PHE ILE ALA VAL ILE ILE LEU SER GLY ASP ARG SEQRES 16 B 275 PRO GLY LEU LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN SEQRES 17 B 275 ASP ASN LEU LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU SEQRES 18 B 275 ASN HIS PRO GLU SER SER GLN LEU PHE ALA LYS LEU LEU SEQRES 19 B 275 GLN LYS MET THR ASP LEU ARG GLN ILE VAL THR GLU HIS SEQRES 20 B 275 VAL GLN LEU LEU GLN VAL ILE LYS LYS THR GLU THR ASP SEQRES 21 B 275 MET SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP SEQRES 22 B 275 LEU TYR SEQRES 1 C 22 THR ASN MET GLY LEU GLU ALA ILE ILE ARG LYS ALA LEU SEQRES 2 C 22 MET GLY LYS TYR ASP GLN TRP GLU GLU SEQRES 1 A 275 GLN LEU ASN PRO GLU SER ALA ASP LEU ARG ALA LEU ALA SEQRES 2 A 275 LYS HIS LEU TYR ASP SER TYR ILE LYS SER PHE PRO LEU SEQRES 3 A 275 THR LYS ALA LYS ALA ARG ALA ILE LEU THR GLY LYS THR SEQRES 4 A 275 THR ASP LYS SER PRO PHE VAL ILE TYR ASP MET ASN SER SEQRES 5 A 275 LEU MET MET GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE SEQRES 6 A 275 THR PRO LEU GLN GLU GLN SER LYS GLU VAL ALA ILE ARG SEQRES 7 A 275 ILE PHE GLN GLY CYS GLN PHE ARG SER VAL GLU ALA VAL SEQRES 8 A 275 GLN GLU ILE THR GLU TYR ALA LYS SER ILE PRO GLY PHE SEQRES 9 A 275 VAL ASN LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS SEQRES 10 A 275 TYR GLY VAL HIS GLU ILE ILE TYR THR MET LEU ALA SER SEQRES 11 A 275 LEU MET ASN LYS ASP GLY VAL LEU ILE SER GLU GLY GLN SEQRES 12 A 275 GLY PHE MET THR ARG GLU PHE LEU LYS SER LEU ARG LYS SEQRES 13 A 275 PRO PHE GLY ASP PHE MET GLU PRO LYS PHE GLU PHE ALA SEQRES 14 A 275 VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU SEQRES 15 A 275 ALA ILE PHE ILE ALA VAL ILE ILE LEU SER GLY ASP ARG SEQRES 16 A 275 PRO GLY LEU LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN SEQRES 17 A 275 ASP ASN LEU LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU SEQRES 18 A 275 ASN HIS PRO GLU SER SER GLN LEU PHE ALA LYS LEU LEU SEQRES 19 A 275 GLN LYS MET THR ASP LEU ARG GLN ILE VAL THR GLU HIS SEQRES 20 A 275 VAL GLN LEU LEU GLN VAL ILE LYS LYS THR GLU THR ASP SEQRES 21 A 275 MET SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP SEQRES 22 A 275 LEU TYR SEQRES 1 D 22 THR ASN MET GLY LEU GLU ALA ILE ILE ARG LYS ALA LEU SEQRES 2 D 22 MET GLY LYS TYR ASP GLN TRP GLU GLU HET EEY B 501 18 HET EEY A 501 18 HETNAM EEY 2-CHLORO-5-NITRO-N-(PYRIDIN-4-YL)BENZAMIDE FORMUL 5 EEY 2(C12 H8 CL N3 O3) FORMUL 7 HOH *532(H2 O) HELIX 1 AA1 ASN B 205 PHE B 226 1 22 HELIX 2 AA2 THR B 229 THR B 238 1 10 HELIX 3 AA3 ASP B 251 GLU B 259 1 9 HELIX 4 AA4 GLU B 276 ARG B 288 1 13 HELIX 5 AA5 SER B 289 SER B 302 1 14 HELIX 6 AA6 GLY B 305 LEU B 309 5 5 HELIX 7 AA7 ASP B 310 LEU B 333 1 24 HELIX 8 AA8 ARG B 350 LEU B 356 1 7 HELIX 9 AA9 PRO B 359 PHE B 363 5 5 HELIX 10 AB1 MET B 364 LEU B 377 1 14 HELIX 11 AB2 ASP B 380 LEU B 393 1 14 HELIX 12 AB3 ASN B 402 HIS B 425 1 24 HELIX 13 AB4 GLN B 430 LYS B 458 1 29 HELIX 14 AB5 HIS B 466 ASP B 475 1 10 HELIX 15 AB6 MET C 2339 MET C 2350 1 12 HELIX 16 AB7 SER A 208 PHE A 226 1 19 HELIX 17 AB8 THR A 229 THR A 238 1 10 HELIX 18 AB9 ASP A 251 GLY A 258 1 8 HELIX 19 AC1 GLY A 258 LYS A 263 1 6 HELIX 20 AC2 PHE A 282 SER A 289 1 8 HELIX 21 AC3 SER A 289 SER A 302 1 14 HELIX 22 AC4 ASP A 310 LEU A 333 1 24 HELIX 23 AC5 SER A 342 GLY A 344 5 3 HELIX 24 AC6 ARG A 350 LEU A 356 1 7 HELIX 25 AC7 PRO A 359 PHE A 363 5 5 HELIX 26 AC8 MET A 364 LEU A 377 1 14 HELIX 27 AC9 ASP A 380 LEU A 393 1 14 HELIX 28 AD1 ASN A 402 HIS A 425 1 24 HELIX 29 AD2 GLN A 430 LYS A 458 1 29 HELIX 30 AD3 HIS A 466 LYS A 474 1 9 HELIX 31 AD4 GLY D 2340 MET D 2350 1 11 SHEET 1 AA1 4 PHE B 247 ILE B 249 0 SHEET 2 AA1 4 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 AA1 4 GLY B 338 ILE B 341 -1 N ILE B 341 O GLY B 346 SHEET 4 AA1 4 MET B 334 ASN B 335 -1 N ASN B 335 O GLY B 338 SHEET 1 AA2 4 PHE A 247 ILE A 249 0 SHEET 2 AA2 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 AA2 4 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 SHEET 4 AA2 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 LINK SG CYS B 285 C03 EEY B 501 1555 1555 1.80 LINK SG CYS A 285 C03 EEY A 501 1555 1555 1.79 CISPEP 1 LYS B 358 PRO B 359 0 0.87 CISPEP 2 LYS A 358 PRO A 359 0 2.49 SITE 1 AC1 14 ILE B 281 PHE B 282 CYS B 285 GLN B 286 SITE 2 AC1 14 HIS B 323 TYR B 327 PHE B 363 MET B 364 SITE 3 AC1 14 LYS B 367 HIS B 449 TYR B 473 LEU B 476 SITE 4 AC1 14 TYR B 477 HOH B 623 SITE 1 AC2 22 PHE A 282 GLN A 283 GLY A 284 GLN A 286 SITE 2 AC2 22 PHE A 287 ARG A 288 SER A 289 HIS A 323 SITE 3 AC2 22 TYR A 327 PHE A 363 MET A 364 LYS A 367 SITE 4 AC2 22 HIS A 449 LEU A 452 TYR A 473 LYS A 474 SITE 5 AC2 22 LEU A 476 TYR A 477 HOH A 666 HOH A 668 SITE 6 AC2 22 HOH A 697 HOH A 704 CRYST1 59.756 93.484 114.607 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016735 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010697 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008725 0.00000